quinoxalines has been researched along with Acute Lymphoid Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barata, JT; Bertaina, A; Buontempo, F; Cappellini, A; Chiarini, F; Evangelisti, C; Fragoso, R; Locatelli, F; Lonetti, A; Manzoli, L; Martelli, AM; Neri, LM; Oliveira, M; Orsini, E; Pession, A; Simioni, C | 1 |
| Bressanin, D; Buontempo, F; Chiarini, F; Fini, M; Martelli, AM; McCubrey, JA; Melchionda, F; Neri, LM; Pession, A; Tabellini, G | 1 |
| Diab-Assef, M; El-Sabban, M; Gali-Muhtasib, H; Haddadin, M; Harakeh, S | 1 |
3 other study(ies) available for quinoxalines and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.
Topics: Antineoplastic Agents; Apoptosis; B-Lymphocytes; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Child; Child, Preschool; Class I Phosphatidylinositol 3-Kinases; Dexamethasone; Glucocorticoids; Heterocyclic Compounds, 3-Ring; Humans; Isoquinolines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Purines; Quinazolinones; Quinoxalines; Thiazolidinediones; Triazines | 2018 |
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Forkhead Box Protein O3; Forkhead Transcription Factors; G2 Phase Cell Cycle Checkpoints; Humans; I-kappa B Kinase; Imidazoles; M Phase Cell Cycle Checkpoints; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; NF-kappa B; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Quinoxalines; Receptor, Notch1; Signal Transduction; Tumor Suppressor Protein p53 | 2012 |
Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide in adult T-cell leukemia cells.
Topics: Adult; Apoptosis; CD4-Positive T-Lymphocytes; Cell Death; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Human T-lymphotropic virus 1; Humans; Jurkat Cells; Leukemia, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinoxalines | 2004 |